v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   311,511,542      
Beginning balance at Dec. 31, 2023 $ 810,415 $ 3 $ 2,453,293 $ 1,270 $ (1,644,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of early exercised options 617   617    
Issuance of common stock upon exercise of vested options (in shares)   3,947,036      
Issuance of common stock upon exercise of vested options 28,936   28,936    
Vesting of restricted stock units (in shares)   6,100,168      
Issuance of common stock under employee stock purchase plan (in shares)   674,155      
Issuance of common stock under employee stock purchase plan 15,603   15,603    
Stock-based compensation 204,531   204,531    
Other comprehensive income (loss), net of tax (3,371)     (3,371)  
Net loss (182,867)       (182,867)
Ending balance (in shares) at Jun. 30, 2024   322,232,901      
Ending balance at Jun. 30, 2024 873,864 $ 3 2,702,980 (2,101) (1,827,018)
Beginning balance (in shares) at Mar. 31, 2024   317,262,580      
Beginning balance at Mar. 31, 2024 845,217 $ 3 2,584,665 (2,333) (1,737,118)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of early exercised options 301   301    
Issuance of common stock upon exercise of vested options (in shares)   1,689,204      
Issuance of common stock upon exercise of vested options 14,402   14,402    
Vesting of restricted stock units (in shares)   3,281,117      
Stock-based compensation 103,612   103,612    
Other comprehensive income (loss), net of tax 232     232  
Net loss (89,900)       (89,900)
Ending balance (in shares) at Jun. 30, 2024   322,232,901      
Ending balance at Jun. 30, 2024 873,864 $ 3 2,702,980 (2,101) (1,827,018)
Beginning balance (in shares) at Dec. 31, 2024   332,885,346      
Beginning balance at Dec. 31, 2024 961,226 $ 3 2,953,080 (2,641) (1,989,216)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of early exercised options $ 126   126    
Issuance of common stock upon exercise of vested options (in shares) 3,225,406 3,225,406      
Issuance of common stock upon exercise of vested options $ 22,103   22,103    
Vesting of restricted stock units (in shares)   6,982,003      
Issuance of common stock under employee stock purchase plan (in shares)   759,484      
Issuance of common stock under employee stock purchase plan 14,195   14,195    
Stock-based compensation 202,845   202,845    
Other comprehensive income (loss), net of tax 12,696     12,696  
Net loss (149,524)       (149,524)
Ending balance (in shares) at Jun. 30, 2025   343,852,239      
Ending balance at Jun. 30, 2025 1,063,667 $ 3 3,192,349 10,055 (2,138,740)
Beginning balance (in shares) at Mar. 31, 2025   339,730,344      
Beginning balance at Mar. 31, 2025 1,025,333 $ 3 3,079,260 2,860 (2,056,790)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested options (in shares)   824,204      
Issuance of common stock upon exercise of vested options 6,161   6,161    
Vesting of restricted stock units (in shares)   3,297,691      
Stock-based compensation 106,928   106,928    
Other comprehensive income (loss), net of tax 7,195     7,195  
Net loss (81,950)       (81,950)
Ending balance (in shares) at Jun. 30, 2025   343,852,239      
Ending balance at Jun. 30, 2025 $ 1,063,667 $ 3 $ 3,192,349 $ 10,055 $ (2,138,740)